LTR Pharma (ASX:LTP) Non Operating Income: A$0.70 Mil (TTM As of Dec. 2025)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

ASX:LTP LTR Pharma Ltd ASX:LTP
7 GF Score
Price A$0.49
View Full Analysis

What is LTR Pharma Non Operating Income?

LTR Pharma ASX:LTP -3.92% 7 Non Operating Income is A$0.70 Mil as of Dec. 2025. GuruFocus rates ASX:LTP with a GF Score™ of 7/100.

Non Operating Income is income or expense that comes from miscellaneous sources. LTR Pharma's Non Operating Income for the six months ended in Dec. 2025 was A$-0.21 Mil. Its Non Operating Income for the trailing twelve months (TTM) ended in Dec. 2025 was A$0.70 Mil.

LTR Pharma Non Operating Income Related Terms

LTR Pharma Non Operating Income Historical Data

* Premium members only.

The historical data trend for LTR Pharma's Non Operating Income can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

LTR Pharma Non Operating Income Chart

LTR Pharma Annual Data
Trend Jun21 Jun22 Jun23 Jun24 Jun25
Non Operating Income
-0.00 -0.00 -0.02 0.03 1.28

LTR Pharma Semi-Annual Data
Jun21 Jun22 Jun23 Dec23 Jun24 Dec24 Jun25 Dec25
Non Operating Income Get a 7-Day Free Trial -0.01 0.04 0.38 0.91 -0.21
ASX:LTP
7GF Score
LTR Pharma Ltd ASX:LTP
Non Operating Income is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

LTR Pharma Non Operating Income Calculation

Non Operating Income is income or expense that comes from miscellaneous sources.

Non Operating Income for the trailing twelve months (TTM) ended in Dec. 2025 adds up the semi-annually data reported by the company within the most recent 12 months, which was A$0.70 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Non Operating Income →
What does a Non Operating Income of A$0.70 Mil mean?
LTR Pharma (ASX:LTP) has a Non Operating Income of A$0.70 Mil as of Dec. 2025. Non-operating Income represents the amount of income from one-time, nonrecurring events. View historical data on LTR Pharma and its competitors.
Is LTR Pharma's Non Operating Income too high?
LTR Pharma's current Non Operating Income is A$0.70 Mil. Overall, LTR Pharma has a GF Score™ of 7/100, reflecting its overall financial health beyond just this single metric.
How does LTR Pharma's Non Operating Income compare to VRTX and REGN?
LTR Pharma's Non Operating Income of A$0.70 Mil can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Non Operating Income for a Biotechnology company?
A good Non Operating Income depends on the Biotechnology industry context. However, Non Operating Income should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Non Operating Income mean?
A high Non Operating Income can signal that a stock is expensive relative to its fundamentals. Non-operating Income represents the amount of income from one-time, nonrecurring events. View historical data on LTR Pharma and its competitors. LTR Pharma's current Non Operating Income is A$0.70 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is LTR Pharma stock overvalued right now?
LTR Pharma (ASX:LTP) has a current Non Operating Income of A$0.70 Mil. The current Non Operating Income is A$0.70 Mil. LTR Pharma's overall GF Score™ is 7/100. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Non Operating Income calculated?
Non Operating Income is calculated from a company's financial statements. For LTR Pharma (ASX:LTP), the current Non Operating Income is A$0.70 Mil as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

LTR Pharma Business Description

Address 9A/204 Alice Street, Brisbane, QLD, AUS, 4000
LTR Pharma Ltd is a clinical stage pharmaceutical company focused on holistically improving men's health, physically and mentally, through the commercialization of an intranasal spray treatment for Erectile Dysfunction. SPONTAN is a Vardenafil-based nasal delivery formulation designed to be a lower dose fast-acting administration that provides a rapid and high availability to a patient's bloodstream compared with the incumbent oral ED treatment products on the market.
7GF Score

Get the complete analysis for ASX:LTP

Non Operating Income is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

A$0.49
Price